BioGeneration Ventures
Investor profile
Venture capital
Deals
9
distinct rounds
Companies
8
backed
Active span
2014–2024
11 yrs
Total round €
€300M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Forbion3
- Novartis Venture Fund2
- Seventure Partners2
- Thuja Capital2
- Bayern Kapital1
- BioMedPartners1
- BOM1
- Brandon Capital1
- Cambridge Innovation Capital1
- Chemelot Ventures1
- Citryll’s founders1
- Coparion1
- Curie Capital1
- EIR Ventures1
- First Venture1
- GIMV1
- Hadean Ventures1
- High-Tech Gründerfonds1
- INKEF Capital1
- Innovatiefonds Noord-Holland1
- Innovation Industries1
- Jeito Capital1
- Johnson & Johnson1
- Nordic Life Science1
- Oxford Science Enterprises1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Citryll | Netherlands | 2 | €104M |
| Complement Therapeutics | Germany | 1 | €72M |
| CatalYm | Germany | 1 | €50M |
| Confo Therapeutics | Belgium | 1 | €30M |
| Scenic Biotech | Netherlands | 1 | €28M |
| FundaMental Pharma | Germany | 1 | €10M |
| Cristal Therapeutics | Netherlands | 1 | €6.0M |
| Phosphoenix | Netherlands | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Citryll | Series B | €85M | 2024-12 |
| Complement Therapeutics | Series A | €72M | 2023-04 |
| CatalYm | Series C | €50M | 2022-11 |
| Confo Therapeutics | Series A | €30M | 2019-03 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Citryll | Other | €19M | 2020-02 |
| FundaMental Pharma | Seed | €10M | 2022-11 |
| Cristal Therapeutics | Early VC | €6.0M | 2014-11 |